Class action, MDL No. 3089
Sudafed PE and phenylephrine lawsuit
Buyers of oral decongestants made with phenylephrine, the active ingredient in Sudafed PE, say makers sold the drugs knowing they work no better than a placebo. A federal judge in Brooklyn dismissed the state law claims in October 2024, but on Jul 30, 2026 the Second Circuit revived the claims over products labeled Maximum Strength and brand name drugs approved through a New Drug Application. The cases are back in district court, no class is certified and there is no settlement.
Key facts
What the lawsuit says
Nearly one hundred cases against makers and sellers of over the counter cold medicines containing phenylephrine were combined in In re Oral Phenylephrine Marketing and Sales Practices Litigation, MDL No. 3089, before Judge Brian M. Cogan in Brooklyn. The buyers say the companies knew phenylephrine was ineffective as a nasal decongestant but kept making and selling it.
According to the court's summary of the complaint, the buyers say that by 2016 there was no doubt oral phenylephrine is no better than a placebo, and in 2023 the FDA's Nonprescription Drug Advisory Committee found that the scientific data did not support its use as a decongestant. The defendants include Johnson & Johnson and Kenvue. No court has found that any company misled buyers.
Who qualifies
The buyers seek to represent classes of people who, from 2016 to the present, bought an oral nasal decongestant containing phenylephrine made by the defendants. The bellwether complaint that tested the claims was brought under New York law.
After the appeal, only two groups of claims are alive: claims over products labeled Maximum Strength, and claims over brand name drugs approved through a New Drug Application. Claims that phenylephrine products in general do not work remain dismissed. No class has been certified.
How much you could get and why
No amount has been published. The bellwether complaint brought claims under New York's consumer protection and false advertising statutes, the New York commercial code and New York common law, which allow damages if a buyer proves the claims. There is no settlement, verdict or claim form, so no per person figure exists.
How to join
There is no sign up form or claim form. If a class is certified or a settlement is approved, class members would get notice explaining how to file. Keep receipts or store records of phenylephrine products labeled Maximum Strength if you have them. Claim can alert you if this case opens a claim process.
Timeline
- 2023: The FDA advisory committee finds the data do not support oral phenylephrine as a decongestant.
- Oct 29, 2024: Judge Cogan dismisses the state law claims as preempted by federal drug law and dismisses the RICO claim.
- Jul 30, 2026: The Second Circuit (Judges Raggi, Chin and Pérez) vacates the dismissal of the Maximum Strength and brand name NDA drug claims, affirms the rest, and sends the cases back (Nos. 24-3296 and 25-119).
- Nov 2026: The cases are back before the district court.
What happens next
The district court will handle the revived Maximum Strength and brand name drug claims under the Second Circuit's opinion. Next steps could include amended complaints, new motions to dismiss, and later a motion to certify classes. A settlement is possible at any point and would need court approval.
Frequently asked questions
Is the Sudafed PE lawsuit real?
Yes. The claims are part of MDL No. 3089 in the Eastern District of New York, and the Second Circuit revived part of them on Jul 30, 2026.
Do I need proof?
Not now, because there is no class or settlement. Receipts for Maximum Strength phenylephrine products could help if a claim process opens.
How much could I get?
No amount has been published, and there is no settlement or award.
Is there a deadline?
No. There is no claim form or deadline while the case is pending.
Does it cost anything?
No. Class members do not pay to be included. Lawyers are paid only from a recovery the court approves.
Do I need a lawyer?
No. Lawyers for the buyers act for the proposed classes. Claim is not a law firm and does not give legal advice.
Claim finds settlements you qualify for and helps you file.
Get alerts if this case pays

